ERD, is associated with measurable changes in concentrations of lipid mediators involved in inflammation and pain modulation, ...
News-Medical.Net on MSN
Antihypertensive and lipid-lowering drugs show efficacy against steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one ...
New research has uncovered a mechanism for parents to pass down longevity, to their progeny, via changes to their lysosome ...
The first European joint guidelines on myocarditis and pericarditis1 mark a significant step forward in unifying the ...
News-Medical.Net on MSN
Cell messengers signal amyloid plaque buildup in obese individuals
Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more precise link between obesity and Alzheimer's disease has remained a mystery – until now.
Metabolic syndrome (MetS) is a collection of disorders that include abdominal obesity, hypertension (HTN), dyslipidemia ...
Background/aim Frequent premature ventricular complexes (PVCs) have historically been regarded as benign in structurally ...
This presentation will highlight emerging research and formulation strategies that expand the use of lipid excipients in oral ...
Medical crewmembers focus on how the flight affects the patient. At altitude, the balloon inside an endotracheal tube could ...
For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the cardiometabolic risk factors (CMRFs) of high blood pressure, glucose intolerance, and low high-density ...
Testing for lipoprotein(a) (Lp[a]) increased from 2015 to 2024, but is still low, according to a study published online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results